Antimicrobial Stewardship in the Context of COVID-19

Sue Overton, MUS Team Administrator, Medicines Use and Safety (SPS)Event 8 July 2020Location Podcast

Good antimicrobial stewardship needs to continue, irrespective of the COVID-19 pandemic


8 July 2020



About the event

In this webinar, Diane discussed the importance of continuing to focus on tackling antimicrobial resistance, and prudent use of antimicrobials during the COVID-19 pandemic. Key principles to consider concerning the impact of COVID-19 on antimicrobial stewardship practice were also covered.

Why it’s important

The principles of good antimicrobial stewardship still need to be maintained.

What was covered

The following points were addressed during the presentation:

  • Importance of continuing to focus on tackling AMR and prudent use of antimicrobials during COVID-19 pandemic
  • Antimicrobial use surveillance in the context of COVID-19 (interim results)
  • National AMS interventions in response to COVID-19
  • Impact of COVID-19 on AMS practice (UKCPAPIN – interim results)


A range of speakers ran this event from SPS and other organisations

SPS speakers

This session was facilitated by Dr Barry Jubraj and you can read more about Barry by following the link.

Non-SPS speakers

Presented by:

Dr Diane Ashiru-Oredope

Lead Pharmacist, HCAI and AMR
National Infection Service, UKHSA (formerly known as PHE)


Access the recording of the podcast

Presentation resources

Slides from the presentation are now available below

Contact us

Contact the Admin Team if you have any questions